The journal of nutrition health & aging 2009-04-01

What we have learned from the Xaliproden Sanofi-aventis trials.

P Douillet, J M Orgogozo

Index: J. Nutr. Health Aging 13(4) , 365-6, (2009)

Full Text: HTML

Abstract

Related Compounds

  • Xaliproden hydroch...

Related Articles:

5-HT1A receptors are involved in the effects of xaliproden on G-protein activation, neurotransmitter release and nociception.

2009-09-01

[Br. J. Pharmacol. 158(1) , 232-42, (2009)]

Magnetic resonance imaging of the neuroprotective effect of xaliproden in rats.

2002-06-01

[Invest. Radiol. 37(6) , 321-7, (2002)]

The neuroprotective agent SR 57746A abrogates experimental autoimmune encephalomyelitis and impairs associated blood-brain barrier disruption: implications for multiple sclerosis treatment.

1999-10-26

[Proc. Natl. Acad. Sci. U. S. A. 96(22) , 12855-9, (1999)]

SR57746A: a survival factor for motor neurons in vivo.

1998-10-01

[J. Neurol. Sci. 160 Suppl 1 , S92-6, (1998)]

Administration of amyloid beta-peptides in the rat medial septum causes memory deficits: reversal by SR 57746A, a non-peptide neurotrophic compound.

1996-08-02

[Neurosci. Lett. 213(2) , 79-82, (1996)]

More Articles...